NewsWhore
04-06-2009, 08:50 AM
LONDON (Reuters) - AstraZeneca Plc faces a delay in marketing its asthma drug Symbicort to young children in the United States after regulators asked for more information, dealing a blow to an importa...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/23356396/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/23356396/)